Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to expand brain cancer trials in the UK.

The Department is committed to ensuring that all patients, including those with brain cancer, have access to cutting-edge clinical trials and innovative, lifesaving treatments.

The Department is committed to turbocharging clinical research and delivering better patient care, to make the United Kingdom a world-leading destination for clinical research. We are working to fast-track clinical trials to drive global investment into life sciences, improve health outcomes, and accelerate the development of medicines and therapies of the future, including treatments for brain cancer.

In December 2025, the Department, through the National Institute for Health and Care Research, announced an initial £13.7 million investment in the pioneering Brain Tumour Research Consortium to accelerate research into new brain tumour treatments. Significant further funding is due to be awarded shortly. The world-leading consortium aims to transform outcomes for adults and children and their families who are living with brain tumours, ultimately reducing lives lost to cancer.

The Government also supports the Rare Cancers Private Members Bill. The bill will make it easier for clinical trials on brain cancer to take place in England, by ensuring the patient population can be more easily contacted by researchers.